High-performance liquid chromatography assay of N,N-dimethyl-p-toluidine released from bone cements: evidence for toxicity. 1997

S Stea, and D Granchi, and C Zolezzi, and G Ciapetti, and M Visentin, and D Cavedagna, and A Pizzoferrato
Laboratory for Biocompatibility Research on Implant Materials, Istituti Ortopedici Rizzoli, Bologna, Italy.

Five commercially available bone cements were analysed by high-performance liquid chromatography for detecting the residual content of an accelerator, the amine N,N-dimethyl-p-toluidine (DMPT), after curing. It was found that the concentration of DMPT in aqueous extracts decreases with time, being almost absent 7 days after curing. Differences were noticed among the cements; residual DMPT is higher in cements prepared with higher content of the amine. It is verified that DMPT's toxic effect on cell cultures is dose-related; a delay in the cell replication cycle is induced in vitro. Damage is reversible, thus justifying the low bone cement toxicity that is clinically ascertained.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D001843 Bone Cements Adhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate with a sodium phosphate solution is also a useful bone paste. Bone Cement,Bone Glues,Bone Pastes,Bone Glue,Bone Paste,Cement, Bone,Cements, Bone,Glue, Bone,Glues, Bone,Paste, Bone,Pastes, Bone
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma
D014052 Toluidines Any of three isomeric compounds (ortho-, meta-, and para-) containing a benzene ring with a methyl and amino group attached to it. They are suspected CARCINOGENS. Aminotoluene

Related Publications

S Stea, and D Granchi, and C Zolezzi, and G Ciapetti, and M Visentin, and D Cavedagna, and A Pizzoferrato
January 1975, Journal of dental research,
S Stea, and D Granchi, and C Zolezzi, and G Ciapetti, and M Visentin, and D Cavedagna, and A Pizzoferrato
January 1987, Aktuelle Probleme in Chirurgie und Orthopadie,
S Stea, and D Granchi, and C Zolezzi, and G Ciapetti, and M Visentin, and D Cavedagna, and A Pizzoferrato
January 2006, Methods in molecular biology (Clifton, N.J.),
S Stea, and D Granchi, and C Zolezzi, and G Ciapetti, and M Visentin, and D Cavedagna, and A Pizzoferrato
December 1980, Neuroscience letters,
S Stea, and D Granchi, and C Zolezzi, and G Ciapetti, and M Visentin, and D Cavedagna, and A Pizzoferrato
April 2017, Archives of toxicology,
S Stea, and D Granchi, and C Zolezzi, and G Ciapetti, and M Visentin, and D Cavedagna, and A Pizzoferrato
January 1993, Environmental and molecular mutagenesis,
S Stea, and D Granchi, and C Zolezzi, and G Ciapetti, and M Visentin, and D Cavedagna, and A Pizzoferrato
February 1991, Contact dermatitis,
S Stea, and D Granchi, and C Zolezzi, and G Ciapetti, and M Visentin, and D Cavedagna, and A Pizzoferrato
November 1981, Chemical & pharmaceutical bulletin,
S Stea, and D Granchi, and C Zolezzi, and G Ciapetti, and M Visentin, and D Cavedagna, and A Pizzoferrato
March 1984, Journal of chromatography,
S Stea, and D Granchi, and C Zolezzi, and G Ciapetti, and M Visentin, and D Cavedagna, and A Pizzoferrato
January 1990, Biochimica et biophysica acta,
Copied contents to your clipboard!